Author: Novarum DX
A specialist in mobile test reader solutions has strengthened its senior leadership team with the appointment of former Skype®, eBay® and Microsoft® customer engagement director to their strategic advisory committee.
Headquartered in Edinburgh, Novarum DX™ welcome the appointment of Diana Easley to the strategic advisory committee. Diana Easley brings unrivalled expertise from senior customer engagement roles at some of the world’s leading technology businesses, which is invaluable knowledge in support of Novarum’s objectives for growth.
Novarum DX™, which was acquired by specialist diagnostics business the BBI Group™ in October 2016, increased revenue by 78 per cent during the 2015/16 financial year and is on course to continue this strong growth trajectory, with ambitious plans to double its existing team over the next 12 months.
Dr Neil Polwart, Novarum DX™ founder and BBI Group™ Head of Mobile, said: “Novarum DX™ has experienced an outstanding period of growth over the last 18 months and the guidance and expertise offered by our non-executive advisors have played a key part in that journey.”
“We’re delighted to be welcoming Diana on board as we formalise the involvement of our existing advisors and set the course for further expansion.”
Dr. Neil Polwart continued: “Diana has helped to shape customer engagement strategy at some of the world’s most innovative and recognised brands and it’s great to be able to draw upon this vast knowledge and experience, which is a great fit with our current advisors.”
Novarum’s highly-innovative mobile test reader solution facilitates the reading and sharing of disposable test results with multiple applications across medical, food, veterinary and aviation industries at a low total cost of ownership.
The company’s smartphone readers enable tests to be carried out remotely and in challenging environments, with the results instantly and accurately available before being shared with a recipient – using nothing more than a smartphone.
The app is used by some of the diagnostic industry’s biggest brands and Novarum also works with smaller, more nimble specialists developing new approaches to target and treat infectious disease, toxicology and autoimmune disease.
Novarum’s current advisory group which includes innovation, strategy and marketing expert Andrew Tubb, who has more than 20 years’ industry experience including over a decade working at global pharma giant Sanofi; and mobile computer vision expert Anthony Ashbrook – who has helped to shape the company’s technology and intellectual property strategy.